Overview
Arpankumar Thaker is a primary care provider, practicing in Internal Medicine in Newark, Delaware. Dr. Thaker has been practicing medicine for over 17 years and is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. His top areas of expertise are Gastrointestinal Bleeding, Anemia, End-Stage Renal Disease (ESRD), Endoscopy, and Ureteroscopy. Dr. Thaker is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
4755 Ogletown Stanton Rd, Newark, DE 19718
Wei Zhao is a primary care provider, practicing in Internal Medicine in Philadelphia, Pennsylvania. Dr. Zhao is rated as a Distinguished provider by MediFind in the treatment of Neurotoxicity Syndromes. His top areas of expertise are Microsporidiosis, Lung Cancer, Lung Adenocarcinoma, Endoscopy, and Coronary Artery Bypass Graft (CABG).
Christiana Care Health Services Inc
Afshin Khams is a primary care provider, practicing in Internal Medicine in Newark, Delaware. Dr. Khams is rated as a Distinguished provider by MediFind in the treatment of Neurotoxicity Syndromes. His top areas of expertise are Necrosis, Acute Pancreatitis, Viral Gastroenteritis, Endoscopy, and Ureteroscopy.
Christiana Care Health Services Inc
Harvey Lee is a primary care provider, practicing in Internal Medicine in Newark, Delaware. Dr. Lee is rated as an Advanced provider by MediFind in the treatment of Neurotoxicity Syndromes. His top areas of expertise are End-Stage Renal Disease (ESRD), Neurotoxicity Syndromes, Stroke, Gastrostomy, and Colonoscopy. Dr. Lee is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Gastrointestinal BleedingDr. Thaker isDistinguished. Learn about Gastrointestinal Bleeding.
- Advanced
- Acute Kidney FailureDr. Thaker isAdvanced. Learn about Acute Kidney Failure.
- AnemiaDr. Thaker isAdvanced. Learn about Anemia.
- Atypical PneumoniaDr. Thaker isAdvanced. Learn about Atypical Pneumonia.
- End-Stage Renal Disease (ESRD)Dr. Thaker isAdvanced. Learn about End-Stage Renal Disease (ESRD).
- Gitelman SyndromeDr. Thaker isAdvanced. Learn about Gitelman Syndrome.
- Heart FailureDr. Thaker isAdvanced. Learn about Heart Failure.
- Experienced
- Acute Arterial Occlusion of KidneyDr. Thaker isExperienced. Learn about Acute Arterial Occlusion of Kidney.
- Acute Interstitial PneumoniaDr. Thaker isExperienced. Learn about Acute Interstitial Pneumonia.
- Acute PancreatitisDr. Thaker isExperienced. Learn about Acute Pancreatitis.
- Acute Tubular NecrosisDr. Thaker isExperienced. Learn about Acute Tubular Necrosis.
- Alcoholic NeuropathyDr. Thaker isExperienced. Learn about Alcoholic Neuropathy.
- ALK-Positive Non-Small Cell Lung CancerDr. Thaker isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.